| The FTSE Med Index Committee approved the following changes to the FTSE Med 100 Index. The changes will be effective after the close of business on Friday, 20 May 2005 (i.e. on Monday, 23 May 2005). |
PERIODIC REVIEW OF CONSTITUENTS Additions to the FTSE Med 100 Index: | Stock Name | Sedol | Country | Rank | Investability Weight | Reason | | Scitex | 6321664 | Israel | 84 | 100% | Auto Addition |
Deletions from the FTSE Med 100 Index: | Stock Name | Sedol | Country | Rank | Reason | | Elbisco Holding | 4420949 | Greece | N/A | Failed Liquidity |
Reserve list for the FTSE Med 100 Index: With immediate effect, the following reserve list will be used in the event that one or more constituents are deleted during the period up to the next semi-annual review: | Stock Name | Sedol | Country | Rank | Investability Weight | | Sarantis | 7124958 | Greece | 85 | 75% | | Minoan Lines (Cr) | 5447754 | Greece | 86 | 100% | | Gek Group | 4421704 | Greece | 91 | 75% | | Suny Electronic Inc Ltd | 6767741 | Israel | 96 | 20% | | Delta Holdings | 4260190 | Greece | 100 | 30% |
Investability Weight Changes for the FTSE Med 100 Index: There are no investability weight changes for the FTSE Med 100 Index. For index related enquiries or further information about FTSE please contact: | Client Services in UK: | Tel: +44 (0) 20 7448 1810 and | | Client Services in US: | Tel: +1 212 825 1328 or +1 415 445 5660 and | | Client Services in Asia Pacific: | Tel: +852 2230 5800 or +65 6223 3738. |
Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com | 